NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr | ₹146 Cr |
What is the latest Trade Payables ratio of NATCO PHARMA ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹275 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹264 Cr |
| Mar2022 | ₹162 Cr |
| Mar2021 | ₹146 Cr |
How is Trade Payables of NATCO PHARMA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹275 Cr | 16.73 | |
| Mar2024 | ₹236 Cr | -10.73 | |
| Mar2023 | ₹264 Cr | 63.04 | |
| Mar2022 | ₹162 Cr | 10.67 | |
| Mar2021 | ₹146 Cr | - | |
Compare Trade Payables of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,523.7 Cr | 3.2% | 17.5% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.2% |
17.5% |
30.2% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses